Loading organizations...
Loading organizations...
Biotechnology company developing therapies for autoimmune diseases.
Syntimmune has raised $68.0M across 3 funding rounds.
Syntimmune has raised $68.0M in total across 3 funding rounds.
Syntimmune has raised $68.0M in total across 3 funding rounds.
Syntimmune's investors include Sam Hall, Apple Tree Partners, Baxalta Ventures, Partners Innovation Fund, David de Graaf.
Syntimmune has raised $68.0M across 3 funding rounds. Most recently, it raised $50.0M Series B in June 2017.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 21, 2017 | $50.0M Series B | Sam Hall | |
| Nov 17, 2016 | $8.0M Series A Extension | Apple Tree Partners, Baxalta Ventures, Partners Innovation Fund | |
| Mar 22, 2016 | $10.0M Series A Extension | David de Graaf, Baxalta Ventures | Partners Innovation Fund |